Asset Advisors Investment Management, LLC Abbott Laboratories Transaction History

Asset Advisors Investment Management, LLC

$1.05 Billion
Q3 2025

A detailed history of Asset Advisors Investment Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Asset Advisors Investment Management, LLC holds 113,573 shares of ABT stock, worth $14.8 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

113,573

Previous 111,832 1.56%

Holding current value

$14.8 Million

Previous $15.2 Million 0.01%

% of portfolio

1.46%

Previous 1.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$120.51 - $136.62 $209,807 - $237,855	1,741 Added 1.56%	113,573 $15.2 Million
Q2 2025 Jul 21, 2025	BUY	$123.95 - $138.08 $72,510 - $80,776	585 Added 0.53%	111,832 $15.2 Million
Q1 2025 May 02, 2025	BUY	$111.1 - $140.22 $412,403 - $520,496	3,712 Added 3.45%	111,247 $14.8 Million
Q4 2024 Feb 04, 2025	SELL	$111.93 - $119.39 $106,893 - $114,017	-955 Reduced 0.88%	107,535 $12.2 Million
Q3 2024 Nov 26, 2024	SELL	$100.07 - $118.13 $140,298 - $165,618	-1,402 Reduced 1.28%	108,490 $12.4 Million

Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $184,839 - $206,327	-1,835 Reduced 1.64%	109,892 $11.4 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $20,261 - $22,377	185 Added 0.17%	111,727 $12.7 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $204,550 - $250,387	-2,268 Reduced 1.99%	111,542 $12.3 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $104,796 - $125,738	-1,097 Reduced 0.95%	113,810 $11 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $211,638 - $235,809	-2,100 Reduced 1.79%	114,907 $12.5 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $28,379 - $33,404	-293 Reduced 0.25%	117,007 $11.8 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $60,838 - $71,372	-640 Reduced 0.54%	117,300 $12.9 Million
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $183,844 - $212,857	-1,900 Reduced 1.59%	117,940 $11.4 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $445,025 - $537,893	-4,360 Reduced 3.51%	119,840 $13 Million
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $166,469 - $202,998	-1,460 Reduced 1.16%	124,200 $14.7 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $34,659 - $42,438	-300 Reduced 0.24%	125,660 $17.7 Million
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $456,140 - $504,624	-3,910 Reduced 3.01%	125,960 $14.9 Million
Q2 2021 Jul 16, 2021	SELL	$105.79 - $124.53 $176,669 - $207,965	-1,670 Reduced 1.27%	129,870 $15.1 Million
Q1 2021 Apr 15, 2021	BUY	$108.84 - $128.23 $45,168 - $53,215	415 Added 0.32%	131,540 $15.9 Million
Q4 2020 Jan 21, 2021	BUY	$105.0 - $114.42 $778,155 - $847,966	7,411 Added 5.99%	131,125 $14.4 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $10,080 - $12,241	-110 Reduced 0.09%	123,714 $13.5 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $121,057 - $154,938	-1,581 Reduced 1.26%	123,824 $11.3 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $367,497 - $537,381	-5,850 Reduced 4.46%	125,405 $9.9 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $179,787 - $200,146	-2,290 Reduced 1.71%	131,255 $11.3 Million
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $910,879 - $987,676	11,130 Added 9.09%	133,545 $11.2 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $411,407 - $479,825	5,645 Added 4.83%	122,415 $10.3 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $119,196 - $144,108	-1,800 Reduced 1.52%	116,770 $9.34 Million
Q4 2018 Jan 28, 2019	BUY	$65.56 - $74.27 $124,891 - $141,484	1,905 Added 1.63%	118,570 $8.58 Million
Q3 2018 Oct 26, 2018	BUY	$60.81 - $73.36 $7.09 Million - $8.56 Million	116,665 New	116,665 $8.56 Million

Others Institutions Holding ABT

# of Institutions

3,650

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.

Account

Asset Advisors Investment Management, LLC Abbott Laboratories Transaction History